FilingReader Intelligence
Zhejiang Medicine lifts profit forecast, announces dividend
July 14, 2025 at 09:41 AM UTC•By FilingReader AI
Zhejiang Medicine projects net profit of 600 million to 720 million yuan for the first half of 2025, representing a significant increase driven by strong demand for its life nutrition products.
The company will distribute a cash dividend of 0.37 yuan per share for 2024, with the ex-dividend date set for July 21, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Zhejiang Medicine 2025 Semi-annual Performance Forecast AnnouncementJuly 14, 2025 at 08:00 AM UTC
Zhejiang Medicine's announcement on adjusting the upper limit of share repurchase price after the implementation of the 2024 annual equity distributionJuly 14, 2025 at 08:00 AM UTC
Grandall Lawyers' Legal Opinion on Zhejiang Medicine's Differentiated Dividend DistributionJuly 14, 2025 at 08:00 AM UTC
News Alerts
Get instant email alerts when Zhejiang Medicine publishes news
Free account required • Unsubscribe anytime